"Orphan Drug Production" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Production of drugs or biologicals which are unlikely to be manufactured by private industry unless special incentives are provided by others.
| Descriptor ID |
D009965
|
| MeSH Number(s) |
J01.576.655.750.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Orphan Drug Production".
Below are MeSH descriptors whose meaning is more specific than "Orphan Drug Production".
This graph shows the total number of publications written about "Orphan Drug Production" by people in this website by year, and whether "Orphan Drug Production" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2017 | 3 | 5 | 8 |
| 2018 | 2 | 1 | 3 |
| 2019 | 8 | 0 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Orphan Drug Production" by people in Profiles.
-
Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-?B: A Systematic Review. Viruses. 2021 02 27; 13(3).
-
Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19. JAMA Intern Med. 2020 10 01; 180(10):1273-1274.
-
Fool Me Twice? The Reemergence of Rofecoxib and the Orphan Drug Act. Ann Intern Med. 2019 10 15; 171(8):578-579.
-
Rare pulmonary disease and orphan drugs: a path to the future. Eur Respir Rev. 2019 Sep 30; 28(153).
-
Incentivizing Therapies for Rare Diseases-Reply. JAMA. 2019 08 06; 322(5):465.
-
Reforming the Orphan Drug Act for the 21st Century. N Engl J Med. 2019 Jul 11; 381(2):106-108.
-
Patterns of alternative access: Unpacking the Slovak extraordinary drug reimbursement regime 2012-2016. Health Policy. 2019 08; 123(8):713-720.
-
Orphan Drug Designation and Exclusivity for "Same Drugs". J Law Med Ethics. 2019 06; 47(2):347-349.
-
Orphan drugs - Authors' reply. Lancet. 2019 04 20; 393(10181):1595-1596.
-
The Orphan Drug Act Revisited. JAMA. 2019 Mar 05; 321(9):833-834.